What Is the Mylan Estradiol Patch Shortage?
The Mylan estradiol patch shortage refers to periods when supplies of the transdermal estradiol patch were limited or unavailable in certain markets. The patch is a hormone therapy product used to treat menopausal symptoms and estrogen deficiency.
What Caused the Shortage?
Shortages can result from manufacturing delays, quality issues, or supply chain disruptions. Regulatory actions, production changes, or recalls may also reduce available inventory. Specific reasons vary by region and time.
How Is the Shortage Affecting Patients?
Patients may face delayed access, gaps in therapy, or the need to switch to alternative estradiol products or delivery methods. Healthcare providers may recommend temporary alternatives or adjusted dosing while supply is constrained.
Where Can Patients Find Updates?
Patients and providers can check official drug shortage databases for current availability and alternative options. The U.S. Food and Drug Drug Shortages database provides updated information on estradiol patch availability and manufacturer notifications.
